PL1824523T3 - Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu - Google Patents

Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu

Info

Publication number
PL1824523T3
PL1824523T3 PL05816233T PL05816233T PL1824523T3 PL 1824523 T3 PL1824523 T3 PL 1824523T3 PL 05816233 T PL05816233 T PL 05816233T PL 05816233 T PL05816233 T PL 05816233T PL 1824523 T3 PL1824523 T3 PL 1824523T3
Authority
PL
Poland
Prior art keywords
hyperpolarized
pyruvate
cardiac imaging
cardiac
imaging
Prior art date
Application number
PL05816233T
Other languages
English (en)
Inventor
Mathilde Lerche
René Zandt
Klaes Golman
Mikkel Thaning
Jan-Henrik Ardenkjær-Larsen
Stefan Petersson
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of PL1824523T3 publication Critical patent/PL1824523T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Signal Processing (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PL05816233T 2004-11-19 2005-11-18 Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu PL1824523T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20045058 2004-11-19
EP05816233.0A EP1824523B1 (en) 2004-11-19 2005-11-18 Method of cardiac imaging with the use of hyperpolarized 13c-pyruvate
PCT/NO2005/000434 WO2006054903A2 (en) 2004-11-19 2005-11-18 Method of cardiac imaging with the use of hyperpolarized 13 c-pyruvate

Publications (1)

Publication Number Publication Date
PL1824523T3 true PL1824523T3 (pl) 2013-12-31

Family

ID=36182402

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05816233T PL1824523T3 (pl) 2004-11-19 2005-11-18 Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu

Country Status (13)

Country Link
US (1) US8980224B2 (pl)
EP (1) EP1824523B1 (pl)
JP (1) JP5456256B2 (pl)
KR (1) KR101249634B1 (pl)
CN (1) CN101102799B (pl)
AU (1) AU2005307194B2 (pl)
BR (1) BRPI0518302A2 (pl)
CA (1) CA2587795C (pl)
ES (1) ES2422558T3 (pl)
MX (1) MX2007006048A (pl)
PL (1) PL1824523T3 (pl)
RU (1) RU2391047C2 (pl)
WO (1) WO2006054903A2 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2393750T3 (es) * 2005-12-16 2012-12-27 Ge Healthcare As Procedimiento para producir carbosilatos hiperpolarizados de aminas orgánicas
US7202665B1 (en) * 2006-04-19 2007-04-10 Wisconsin Alumni Research Foundation Magnetic resonance spectroscopy of species with multiple peaks
EP2081879A2 (en) 2006-07-11 2009-07-29 Cambridge Isotope Laboratories, Inc. Synthesis of isotopically labeled alpha-keto acids and esters
EP2051739A2 (en) * 2006-08-18 2009-04-29 GE Healthcare AS Imaging medium comprising lactate and hyperpolarised 13c-pyruvate
US8951500B2 (en) 2006-08-18 2015-02-10 Ge Healthcare As 13C-MR imaging or spectroscopy of cell death
WO2008026937A1 (en) 2006-08-30 2008-03-06 Ge Healthcare As Method of dynamic nuclear polarisation (dnp) and compounds and compositions for use in the method
MX2009004899A (es) * 2006-11-21 2009-05-21 Ge Healthcare As Metodo para manejar pacientes con cancer.
WO2008086534A1 (en) 2007-01-11 2008-07-17 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US8483798B2 (en) * 2007-01-15 2013-07-09 General Electric Company System and method for metabolic MR imaging of a hyperpolarized agent
US11224635B2 (en) 2007-03-27 2022-01-18 Venturis Thereuptics, Inc. Therapeutic angiogenesis for treatment of the spine and other tissues
US8983570B2 (en) * 2007-03-27 2015-03-17 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treatment of the spine
US7470813B2 (en) 2007-03-30 2008-12-30 Ge Healthcare Limited Method for the production of pyruvic acid
RU2494672C2 (ru) * 2007-05-17 2013-10-10 Дженерал Электрик Компани Магнитно-резонансные способы определения категории опухоли с использованием среды для визуализации, содержащей гиперполяризованный 13c-пируват
GB0713074D0 (en) * 2007-07-05 2007-08-15 Univ London A method of hyperpolarising a magnetic resonance agent
WO2009013350A2 (en) * 2007-07-26 2009-01-29 Ge Healthcare Uk Limited Imaging medium comprising hyperpolarised 13 c-lactate and use thereof
CN101796413B (zh) * 2007-09-07 2014-08-20 通用电气健康护理有限公司 测定pdh活性的方法和用于该方法中的成像介质
EP2072061A1 (en) 2007-12-19 2009-06-24 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
WO2009129265A1 (en) 2008-04-14 2009-10-22 Huntington Medical Research Institutes Methods and apparatus for pasadena hyperpolarization
EP2268321B1 (en) 2008-05-02 2013-10-09 General Electric Company Method of determining alanine transaminase (ALT) activity by 13C-MR detection using hyperpolarised 13C-pyruvate
MX2011010294A (es) * 2009-04-02 2012-01-27 Ge Healthcare Ltd Uso de un medio de formacion de imagenes de resonancia magnetica que comprende 13c piruvato hiperpolarizado para la deteccion de inflamacion o infeccion.
WO2011029854A1 (en) 2009-09-10 2011-03-17 Ge Healthcare Limited 13c-mr detection using hyperpolarised 13c-fructose
EP2343568A1 (en) * 2009-12-30 2011-07-13 Koninklijke Philips Electronics N.V. Dynamic nuclear polarization apparatus with sample transport system
RU2547755C2 (ru) * 2010-02-22 2015-04-10 Конинклейке Филипс Электроникс Н.В. Rf антенное устройство и способ восстановления многоядерного mr изображения, включающий в себя параллельную mri
US9452409B2 (en) 2011-04-22 2016-09-27 Vanderbilt University Para-hydrogen polarizer
WO2014009240A1 (en) * 2012-07-13 2014-01-16 Bracco Imaging Spa Triarylmethyl radicals
US9874622B2 (en) 2013-09-27 2018-01-23 General Electric Company Hyperpolarized media transport vessel
KR101516634B1 (ko) * 2014-07-09 2015-05-06 연세대학교 산학협력단 13c-자기공명분광영상을 이용한 암 환자의 치료 예후를 예측하는 방법
RU2622983C1 (ru) * 2016-07-25 2017-06-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ интраоперационной визуализации ишемически-реперфузионного повреждения миокарда
US11500044B2 (en) * 2018-02-19 2022-11-15 Bruker France Sas Nuclear spin hyperpolarization in a porous matrix
US11350888B2 (en) * 2019-09-03 2022-06-07 Siemens Healthcare Gmbh Risk prediction for sudden cardiac death from image derived cardiac motion and structure features

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597548A (en) * 1990-07-18 1997-01-28 Board Of Regents, The University Of Texas System 13 C Isotopomer analyses in intact tissue using (13 C) homonuclear decoupling
JP2001513661A (ja) * 1997-01-08 2001-09-04 ナイコムド イメージング エーエス 磁気共鳴画像法
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US6958244B2 (en) * 2002-04-12 2005-10-25 Bruker Biospin Corp. Low-conductivity buffers for magnetic resonance measurements

Also Published As

Publication number Publication date
EP1824523A2 (en) 2007-08-29
WO2006054903A2 (en) 2006-05-26
KR20070089171A (ko) 2007-08-30
KR101249634B1 (ko) 2013-04-01
CN101102799A (zh) 2008-01-09
RU2391047C2 (ru) 2010-06-10
RU2007118383A (ru) 2008-12-27
CA2587795A1 (en) 2006-05-26
ES2422558T3 (es) 2013-09-12
AU2005307194B2 (en) 2011-02-10
US20090162287A1 (en) 2009-06-25
BRPI0518302A2 (pt) 2008-11-11
AU2005307194A1 (en) 2006-05-26
US8980224B2 (en) 2015-03-17
CN101102799B (zh) 2011-05-04
WO2006054903A3 (en) 2007-03-15
EP1824523B1 (en) 2013-05-01
CA2587795C (en) 2015-01-20
JP2008520335A (ja) 2008-06-19
MX2007006048A (es) 2007-07-25
JP5456256B2 (ja) 2014-03-26

Similar Documents

Publication Publication Date Title
PL1824523T3 (pl) Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu
GB2427362B (en) Imaging catheter
EP1814909A4 (en) USE OF AIMP2DX2 FOR THE DIAGNOSIS AND TREATMENT OF CANCER
EP1933884A4 (en) PICTURES AND METHOD FOR THEIR USE
EP1713395A4 (en) ULTRASONIC IMAGING SYSTEM AND IMAGE FORMING METHODS USING THE SAME
EP1716809A4 (en) TOMOGRAPHY RECONSTRUCTION PROCESS AND TOMOGRAPH
HK1113311A1 (en) Skin preparation for external use
EP1799113A4 (en) CONTINUOUS FIELD TOMOGRAPHY
EP2068768A4 (en) METHOD AND SYSTEM FOR ENHANCING THE DIASTOLIC FUNCTION OF THE HEART
EP1909648A4 (en) SYSTEM AND METHOD FOR GAUGING
IL177719A0 (en) Isolating cardiac circulation
EP1758605A4 (en) PROUROGUANYLIN AS THERAPEUTIC AND DIAGNOSTIC AGENTS
IL178815A0 (en) The treatment of respiratory disease
EP1874800A4 (en) DIAGNOSTIC AND THERAPEUTIC AGENTS
EP1829562A4 (en) MEDICAL PAVING PREPARATION
EP1602061A4 (en) AUTOMATED MEASUREMENT OF ANATOMICAL STRUCTURES IN MEDICAL IMAGING
EP1781685A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS
EP1788939A4 (en) CONTRAST AND MRI METHOD
GB0410399D0 (en) The treatment of respiratory disease
EP1838260A4 (en) SYSTEM AND METHOD FOR TREATMENT OF CARDIAC TISSUE
EP1870710A4 (en) BIOMARKERS FOR DIAGNOSIS OF DISEASE AND USE THEREOF
EP1606418A4 (en) METHODS OF DIAGNOSING AND TREATING EPILEPSY
GB0400976D0 (en) Methods of diagnosis
ZA200609007B (en) Medical plaster for application on the skin
EP1767210A4 (en) MEDICAL USE OF PAEONIFLORIN